The Benefits of Nicotinamide Riboside Upon Cognition and Sleep in Older Veterans

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Poor sleep quality and short sleep duration may be a mechanistic component of cognitive impairment in older adults, associated with a decline in brain-derived neurotrophic factor. Increasing the availability of nicotinamide adenine dinucleotide (NAD+) with supplementation of its precursor, nicotinamide riboside (NR), a form of vitamin B3 may increase the expression of brain-derived neurotrophic factor. This study proposes to examine the benefits of NR supplementation on sleep and cognitive function in older adults with comprehensive subjective and objective measures and to explore its impacts on serum brain-derived neurotrophic factor.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Maximum Age: 85
Healthy Volunteers: t
View:

• Sleep Quality. Pittsburgh Sleep Quality Index (PSQI) global score \>5

Locations
United States
New York
Buffalo Veteran Affairs Medical Center
RECRUITING
Buffalo
State University of New York at Buffalo
NOT_YET_RECRUITING
Buffalo
University at Buffalo State University of New York
NOT_YET_RECRUITING
Buffalo
Contact Information
Primary
Carleara Weiss, PhD, MS, RN
carleara@buffalo.edu
7168282006
Backup
Rebecca A Lorenz, PhD, RN
rlorenz@buffalo.edu
716-829-2204
Time Frame
Start Date: 2023-04-04
Estimated Completion Date: 2027-08-30
Participants
Target number of participants: 50
Treatments
Experimental: Intervention
Participants in the intervention group will receive 500mg of NR twice daily
Placebo_comparator: Placebo
Participants in the intervention group will receive 500mg of sham placebo twice daily
Related Therapeutic Areas
Sponsors
Leads: State University of New York at Buffalo

This content was sourced from clinicaltrials.gov

Similar Clinical Trials